Goniothalamin (GTN) inhibits the development of TNBS-induced colitis in rats.
Moreover, GTN prevents the development of spontaneous colitis in IL-10 deficient mice.
This activity relies on downregulation of TNF-α and upregulation of SIRT-1 expression.
GTN induces intrinsic apoptosis in HT-29 cells, involving ROS, MAPK and caspases.
These results highlight GTN as a potential chemopreventive agent for colon cancer.